1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Commercialization Readiness Pilot (CRP) Program (NIH) is sponsored by National Institutes of Health (NIH). The Commercialization Readiness Pilot Program (CRP) provides additional technical assistance and late-stage research and development support not typically covered within small business Phase II or Phase IIB Strategic Breakthrough awards.
It aims to facilitate the transition of previously funded SBIR/STTR projects to the commercialization stage.
Get alerted about grants like this
Get emailed when new opportunities from “National Institutes of Health (NIH)” or related funders appear. Free, weekly, unsubscribe anytime.
Or search similar grants →According to the current listing, eligibility includes: Only United States small business concerns (SBCs) that have had an active NIH SBIR or STTR Phase II or Phase IIB contract, grant, or cooperative agreement from NIH within the last 36 months are eligible. Confirm the full requirements in the official notice before applying.
Commercialization Readiness Pilot (CRP) Program (NIH) is funded by National Institutes of Health (NIH). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Past winners and funding trends for this program
The memorandum of agreement was signed August 4 and 5, disclosed by House appropriators on September 3, and runs through 2036. It names no dollar figure. Here is what is actually established, what is still speculation, and what researchers holding or planning NIAID biodefense awards should do before September 30.
Read articleOn September 3, 2026 — six days before the FY2027 Pioneer deadline — NIH posted forecast records for the entire FY2028 High-Risk, High-Reward program. The slate is nearly flat against FY2027, Transformative loses a slot, and the dollar figures quietly assume full negotiated indirect rates.
Read articleNOT-RM-26-004 asks the public for NIH-wide research challenges worth a 10-year, cross-institute program. There is no budget, no biosketch, no page limit, and no award. What there is: the five criteria every Common Fund investment has met since 2006, a new bullet about small-lab burden, and a fund whose FY 2026 request came in at $347.4 million — down 49.3 percent.
Read article